Navigation Links
Philips CT iDose4 Iterative Reconstruction Technique Advances Patient Care by Delivering Improved Image Quality at Low Dose
Date:11/22/2011

ANDOVER, Mass., Nov. 22, 2011 /PRNewswire/ -- Royal Philips Electronics (AEX: PHI, NYSE: PHG) today announced that Philips iDose4, the latest generation of Philips iterative reconstruction technique, has nearly 500 sales. While iDose4 only began shipping in March, its success validates the desire of radiologists to be able to both acquire and reconstruct images in less time, with improved image quality at low dose.

(Logo: http://photos.prnewswire.com/prnh/20110726/NY41282LOGO )

iDose is an iterative reconstruction technique that gives radiologists control of the dial so they can personalize image quality depending on clinical needs at low dose. When used in combination with the advanced technologies of the iCT, Ingenuity and Brilliance 64 scanner families, this provides a unique approach to managing important factors in patient care – a new era in low energy, low dose and low injected contrast imaging.

With iDose4, radiologists can personalize image quality based on each patient's specific needs. The iterative reconstruction technique's advanced algorithms provide up to 57 percent improvement in spatial resolution at low dose, and the majority of factory protocols are reconstructed in 60 seconds or less with iDose4.

"We're not just talking about a scan. We're talking about detailed pictures of the coronary arteries being obtained in three seconds noninvasively. That's revolutionary," said Harvey Hecht, M.D., director of cardiovascular CT at Lenox Hill Hospital.

As part of Philips ongoing commitment to streamlining workflow for radiologists, iDose is easy to use and simple for radiologists to adopt into their existing standard of care. Designed to seamlessly integrate into a CT department, iDose provides the look and feel of conventional higher-dose images without long processing times.

"Philips has an ongoing commitment to expand clinical possibilities and patient care," said Jamie Valliant, global director, CT product portfolio, for Philips Healthcare. "Nowhere is this more important than in image quality and at low dose. With iDose4, we provide a personal, holistic approach to patient care."

iDose4 is now available globally for the iCT, Ingenuity CT and Brilliance 64 scanners. It can be integrated into a standard CT department.

For more information, please visit www.philips.com/iDose4.

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs over 120,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.3 billion in 2010, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

 

 

 

 


'/>"/>
SOURCE Royal Philips Electronics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Philips Launches HeartStart FR3 Automated External Defibrillator for Professional Responders Treating Victims of Sudden Cardiac Arrest
2. U.S. Soldiers and Veterans at Home and Abroad Touched by Lifesaving Products From Philips Healthcare
3. Philips Enters North American Mammography Market, Underscoring its Global Commitment to Womens Health Care
4. Philips Respironics Unveils "Pathway to Better Outcomes" for Home Health Care
5. Philips Teams up With Integrated Oncology Network, Reinforcing Its Commitment to the Future of Cancer Care
6. Philips Unveils a Vision for the Future of Cardiac Care at ESC 2011
7. Cardium Announces Receipt of $1.1 Million in Funds from Philips Acquisition of Innercool Therapies
8. Lumalier Partners with Philips Healthcare to Provide Tru-D Solution for Reduction of Environmental Pathogens in Healthcare Facilities
9. Sectra and Philips Sign Large Mammography Modality Acquisition Deal
10. Masimo Announces Rainbow Agreement with Philips
11. Philips and the Heart Rhythm Society Collaborate to Showcase the Electrophysiology (EP) Lab of Today and the Future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... 2016  Results from the Phase II SUSTAIN study ... reduced the median annual rate of sickle cell-related pain ... 2.98, p=0.010) in patients with or without hydroxyurea therapy ... being featured in the official press briefing at the ... Meeting and presented during the Plenary Scientific Session tomorrow ...
(Date:12/2/2016)... December 2, 2016 - bioLytical lanza el INSTI HIV ... la OMS     Continue Reading ... ... , , bioLytical ... anunciado hoy que está expandiendo el lanzamiento de su INSTI HIV Self Test ...
(Date:12/2/2016)... December 2, 2016 According to the ... Market Study on Automated Endoscope Reprocessors: Single Basin Automated Endoscope ... 8.6% Between 2016 and 2024 " the global automated endoscope reprocessors market was ... to expand at a CAGR of 7.2% during an eight-year ... 1,367.6 Mn by 2024. ...
Breaking Medicine Technology:
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to ... advantage of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser ... of age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... will speak at the American Conference Institute’s 21st Drug & Medical Device Litigation ... Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 business, civic, ... to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, ... and operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, ...
(Date:12/2/2016)... ... , ... The annual time frame to change Medicare health and prescription drug ... 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan to ... make changes during this period order for their new policy to go into effect ...
Breaking Medicine News(10 mins):